<DOC>
	<DOCNO>NCT02552160</DOCNO>
	<brief_summary>Prospective , multi-centre , non-interventional study collect finding effect LABA/LAMA ( Long Acting Beta2-Agonists / Long Acting Muscarinic Antagonists ) combination preparation COPD ( Chronic obstructive pulmonary disease ) symptoms quality life real condition find types patient select therapy physician .</brief_summary>
	<brief_title>DETECT-Register DocumEnTation Evaluation COPD Combination Therapy</brief_title>
	<detailed_description>Retrospective aspect documentation : For patient already change fixed-dose combination , lung function parameter CAT ( COPD Assessment Test™ ) score time prior changeover document .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Glycopyrrolate</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<criteria>Female/male least 40 year age Patient diagnose COPD Patient change within last 3 month fixeddose combination ( FDC ) ( Aclidinium/Formeterol , Glycopyrronium/Indacaterol Umeclidinium/Vilanterol ) , already intent change patient fixeddose combination ( Aclidinium/Formeterol , Glycopyrronium/Indacaterol Umeclidinium/Vilanterol ) . Lung function parameter CAT score time prior changeover FDC record ( within last 6 month case patient already change ) determine 1st visit ( case patient yet change changeover intend ) . Signed declaration consent The prescribe information fixeddose combination ( Duaklir® Genuair® , Ulibtro® Breezhaler® Anoro® ) list contraindication patient . Patient pregnant , plan become pregnant , nursing therapy period . Patient suffers hypersensitivity one active ingredient fixeddose combination . Patient participate clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Chronic Obstructive Pulmonary Disease</keyword>
	<keyword>Fixed-dose Combination</keyword>
	<keyword>LAMA/LABA ( Long Acting Beta2-Agonists / Long Acting Muscarinic Antagonists )</keyword>
	<keyword>Inhaler</keyword>
	<keyword>Aclidinium/Formoterol</keyword>
	<keyword>Glycopyrronium/Indacaterol</keyword>
	<keyword>Umeclidinium/Vilanterol</keyword>
</DOC>